Leading a Culture of Innovation
Practices
Diligence is the Hallmark of Our Services
Recent News
Read written Recent News About IP and Technology
GlobeNewswire
2025
LeddarTech to Demonstrate Advanced ADAS Sensor Fusion and Perception Solutions at Auto Shanghai 2025
QUEBEC CITY, Canada, April 01, 2025 (GLOBE NEWSWIRE) -- LeddarTech® Holdings Inc. (“LeddarTech”) (Nasdaq: LDTC), an automotive software company that provides patented disruptive AI-powered low-level sensor fusion and perception software technology, LeddarVisi…...
Read MoreGlobeNewswire
2025
LeddarTech 将在 2025 年上海车展展示先进的 ADAS 传感器融合与感知解决方案
加拿大魁北克市, April 01, 2025 (GLOBE NEWSWIRE) -- LeddarTech® Holdings Inc. （纳斯达克股票代码：LDTC）是一家汽车软件公司，致力于为高级驾驶辅助系统（ADAS）、自动驾驶（AD）及泊车应用提供专利颠覆性AI驱动的底层传感器融合与感知软件技术LeddarVision™。公司今日宣布将参展2025年4月23日至5月2日举办的2025上海国际汽车工业展览会（Auto Shanghai 2025）。...
Read MoreIPWatchdog.com
2025
Champions of IP: Judges Michel & Newman | IPWatchdog Unleashed
This week on IPWatchdog Unleashed, we present the remarks made during the Award Ceremony at IPWatchdog LIVE 2025 on March 3, 2025. This year we once again presented two awards at IPWatchdog LIVE; the Paul Michel Award and the Pauline Newman Award. These two a…...
Read More
Biztoc.com
2025
Nokia and Amazon settle streaming patent dispute
Nokia Oyj and Amazon.com Inc. settled a patent dispute over streaming technologies that had spread to courts across three continents. The agreement covers the use of Nokia video technologies in Amazon’s streaming services and devices, resolving all patent lit…...
Read More
GlobeNewswire
2025
FibroBiologics Reports Full Year 2024 Financial Results and Provides Corporate Update
Proprietary master cell bank of fibroblast-based spheroids product candidate, CYWC628, completed in accordance with Good Manufacturing Practices after successfully passing all required safety testing...
Read MoreGlobeNewswire
2025
Cue Biopharma Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights
BOSTON, March 31, 2025 (GLOBE NEWSWIRE) -- - Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells for the treatment of cance…...
Read MoreOur Insights
Insight, Story & Blog
Design Patents vs. Trade Dress Protection for Product Configurations: A Comprehensive Analysis
Read More
Preparing Your Startup for Capital Raising: A Comprehensive Guide
Read More
Finding Evidence of Inequitable Conduct in Patent Prosecution: A Comprehensive Guide for Attorneys and Inventors
Read More
Navigating the Maze of Trademark Confusion: Key Considerations for Brand Owners
Read More
The Evolving Landscape of Product Configuration Protection: Balancing Innovation and Competition
Read MoreGet in Touch
Ready to work
together? Let's go!
MC Law loves hearing from you. Send us a message to inquire how we can solve your legal issues.
Phone: +1 202.409.1003
Email: contact@mclaw.io
Professionals
OFFICES
PROFESSIONALS
OFFICES
